4D pharma plc (LBPS): Price and Financial Metrics

4D pharma plc (LBPS): $1.65

0.04 (+2.48%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

Add LBPS to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#249 of 486

in industry

LBPS Price/Volume Stats

Current price $1.65 52-week high $11.09
Prev. close $1.61 52-week low $1.50
Day low $1.61 Volume 3,900
Day high $1.65 Avg. volume 221,212
50-day MA $3.31 Dividend yield N/A
200-day MA $5.04 Market Cap 27.11M

LBPS Stock Price Chart Interactive Chart >


4D pharma plc (LBPS) Company Bio


4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company's development programs include Blautix for irritable bowel syndrome and Thetanix for paediatric crohn's disease. It also develops immuno-oncology products comprising MRx0518, MRx0573, and MRx1299 for solid tumors, and MRx0518 for pancreatic cancer; respiratory products, such as MRx-4DP0004 for asthma and COVID-19; central nervous system products, including MRx0005 and MRx0029 for neurodegeneration; and platform products comprising vaccines and autoimmune. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda and MRx0518 in patients with solid tumours. The company was formerly known as Schosween 18 Limited. 4D pharma plc was founded in 2014 and is headquartered in Leeds, the United Kingdom.


LBPS Latest News Stream


Event/Time News Detail
Loading, please wait...

LBPS Latest Social Stream


Loading social stream, please wait...

View Full LBPS Social Stream

LBPS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -75.59%
5-year N/A
YTD N/A
2023 N/A
2022 0.00%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!